Beijing Hotgen Biotech Co Ltd (688068) — Working Capital to Net Assets Ratio
Beijing Hotgen Biotech Co Ltd (688068) has a Working Capital to Net Assets ratio of 36.7% as of September 2025. Working capital of CN¥1.07 Billion (current assets of CN¥1.34 Billion minus current liabilities of CN¥264.32 Million) is measured against net assets of CN¥2.93 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Beijing Hotgen Biotech Co Ltd (688068) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Beijing Hotgen Biotech Co Ltd Working Capital to Net Assets (2016–2024)
This chart shows how Beijing Hotgen Biotech Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 36.7%, reflecting working capital of CN¥1.07 Billion against net assets of CN¥2.93 Billion CNY. See how many days can Beijing Hotgen Biotech Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Beijing Hotgen Biotech Co Ltd (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Hotgen Biotech Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Beijing Hotgen Biotech Co Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 34.4% | CN¥1.06 Billion | CN¥3.07 Billion | CN¥1.29 Billion | CN¥235.89 Million | ▲ +15.2 pp |
| 2023 | 19.2% | CN¥643.21 Million | CN¥3.36 Billion | CN¥828.24 Million | CN¥185.03 Million | ▼ -19.2 pp |
| 2022 | 38.4% | CN¥1.29 Billion | CN¥3.35 Billion | CN¥1.80 Billion | CN¥511.31 Million | ▼ -23.7 pp |
| 2021 | 62.1% | CN¥1.78 Billion | CN¥2.87 Billion | CN¥2.52 Billion | CN¥734.16 Million | ▲ +2.7 pp |
| 2020 | 59.4% | CN¥443.66 Million | CN¥746.79 Million | CN¥587.77 Million | CN¥144.11 Million | ▼ -18.2 pp |
| 2019 | 77.6% | CN¥503.70 Million | CN¥649.30 Million | CN¥549.22 Million | CN¥45.52 Million | ▲ +42.5 pp |
| 2018 | 35.1% | CN¥73.82 Million | CN¥210.44 Million | CN¥129.94 Million | CN¥56.11 Million | ▼ -7.1 pp |
| 2017 | 42.1% | CN¥68.13 Million | CN¥161.65 Million | CN¥96.13 Million | CN¥28.00 Million | ▼ -29.1 pp |
| 2016 | 71.2% | CN¥93.31 Million | CN¥130.98 Million | CN¥121.25 Million | CN¥27.94 Million | — |